Short News

Print

 

short news

Statins, Aspirin may improve survival
in patients with Uterine Cancer

Research presented at the American Society of Clinical Oncology meeting suggests that “statin and aspirin use, but not beta-blocker use, are associated with improved overall survival in patients with uterine malignancies.” Researchers found, “on multivariate analysis,” that “patients on both Statins and aspirin had a 84% decreased risk of death, compared with women who did not have hyperlipidemia and did not take aspirin. (HR=0.16, 95% CI 0.07-0.38).”


PhD Fellows Conference
at Faisalabad

First International Conference of PhD Fellows/Scholars jointly organized by University of Health Sciences and University of Faisalabad at Faisalabad on October 26-27th 2013. For details contact Convener Prof. Junaid Sarfraz Khan UHS Lahore. 042-99231218.


When to stop antithrombotic medication
during medical procedures

“A new guideline has been made available from the American Academy of Neurology on the difficult issue of whether to stop antithrombotic medication during surgery or other medical procedures.” MedPage Today reports that the guideline indicated that “prostate or hernia procedures, electromyography, and saphenous vein ablation might be candidates for continued warfarin or aspirin.” The guideline also says that those undergoing dental procedures not need to stop taking the medication.


 

CBEC calls for applications
for PGD and MBE

KARACHI: Center of Biomedical Ethics and Culture (CBEC), SIUT, in Karachi has run a successful one year Postgraduate Diploma Program (PGD) in Biomedical Ethics since 2006. In 2010, CBEC also initiated a two year long Masters in Bioethics (MBE) program. CBEC is now pleased to announce the first “Call for Applications” for intake of students for the PGD Class of 2014 and MBE Class of 2015. The academic year commences in January 2014.
Details of PGD and MBE programs, including eligibility criteria and admission process, and application forms are available on CBEC website www.siut.org/bioethics. (The deadline for receiving applications is July 12, 2013).
Please note that SIUT may be able to offer free accommodation on twin sharing basis (subject to availability) to out of town students. Please do not hesitate to email us at This email address is being protected from spambots. You need JavaScript enabled to view it. if you require additional information or any clarification.


Study finds Aspirin, Dalteparin equally
effective for VTE prevention

Medscape reports that Aspirin is as effective as dalteparin for venous thromboembolism (VTE) prevention after total hip arthroplasty (THA), according to a study published online June 3 in the journal Annals of Internal Medicine. In the 778-patient trial, the participants were given an initial 10 days of dalteparin prophylaxis after elective THA and then randomly assigned to 28 days of dalteparin 5000 U or aspirin 81 mg once daily. The researchers from the Dalhousie University in Halifax, Nova Scotia, found five (1.3%) of the 398 patients in the dalteparin group experienced a VTE event in the 90-day follow-up period compared with 1 (0.3%) of 380 patients assigned to receive aspirin (absolute difference, 1.0 percentage point; 95% confidence interval [CI], −0.5 to 2.5 percentage points).

 

© Professional Medical Publications. All rights reserved.